Exogenous IGF-1 preserves intestinal VEGF/VEGFR2 expression, endothelial cell proliferation, and microvascular density, improves survival, and attenuates tissue injury in experimental NEC. This evidence concerns the gene IGF1 and necrotizing enterocolitis.